MedPath

CinCor Pharma, Inc.

CinCor Pharma, Inc. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2018-01-01
Employees
15
Market Cap
-
Website
http://www.cincor.com

A Study of CIN-107 in Patients With Uncontrolled Hypertension

Phase 2
Completed
Conditions
Uncontrolled Hypertension
Interventions
Drug: Placebo
First Posted Date
2021-11-30
Last Posted Date
2023-08-01
Lead Sponsor
CinCor Pharma, Inc.
Target Recruit Count
249
Registration Number
NCT05137002
Locations
🇺🇸

CinCor Site 26, McAllen, Texas, United States

🇺🇸

CinCor Site 70, Lynwood, California, United States

🇺🇸

CinCor Site 46, Panorama City, California, United States

and more 59 locations

A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)

Phase 2
Completed
Conditions
Resistant Hypertension
Interventions
Drug: Placebo
First Posted Date
2020-08-20
Last Posted Date
2023-07-24
Lead Sponsor
CinCor Pharma, Inc.
Target Recruit Count
275
Registration Number
NCT04519658
Locations
🇺🇸

CinCor Site 89, Miami, Florida, United States

🇺🇸

CinCor Site 47, Las Vegas, Nevada, United States

🇺🇸

CinCor Site 7, Cincinnati, Ohio, United States

and more 77 locations
© Copyright 2025. All Rights Reserved by MedPath